Jacobien K. von Frijtag Drabbe Künzel

New, Non-Adenosine, High-Potency Agonists for the Human Adenosine A_2B Receptor with an Improved Selectivity Profile Compared to the Reference Agonist <i>N</i>-Ethylcarboxamidoadenosine

Margot W. Beukers, Lisa C. W. Chang, Jacobien K. von Frijtag Drabbe Künzel et al. · Journal of Medicinal Chemistry · 2004 · 150 citations · Full text

2-Amino-6-furan-2-yl-4-substituted Nicotinonitriles as A_2A Adenosine Receptor Antagonists

Monica Mantri, Olivier de Graaf, Jacobus van Veldhoven et al. · Journal of Medicinal Chemistry · 2008 · 144 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +14

A Series of Ligands Displaying a Remarkable Agonistic−Antagonistic Profile at the Adenosine A₁ Receptor

Lisa C. W. Chang, Jacobien K. von Frijtag Drabbe Künzel, Thea Mulder‐Krieger et al. · Journal of Medicinal Chemistry · 2004 · 114 citations · Full text

Molecular Pharmacology, Biochemistry, Functional Selectivity +15

2,4,6-Trisubstituted Pyrimidines as a New Class of Selective Adenosine A₁ Receptor Antagonists

Lisa C. W. Chang, Ronald F. Spanjersberg, Jacobien K. von Frijtag Drabbe Künzel et al. · Journal of Medicinal Chemistry · 2004 · 94 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Adenosine Receptors +15

Derivatives of the Triazoloquinazoline Adenosine Antagonist (CGS 15943) Having High Potency at the Human A_2Band A₃Receptor Subtypes

Yong Chul Kim, Maarten de Zwart, Louis W. Chang et al. · Journal of Medicinal Chemistry · 1998 · 92 citations · Full text

Adenosine Receptors, Pharmacotherapy, Experimental Pharmacology +16